The Leicester Vascular Institute, Glenfield Hospital, Leicester UK.
The Leicester Vascular Institute, Glenfield Hospital, Leicester UK.
Eur J Vasc Endovasc Surg. 2019 Apr;57(4):477-486. doi: 10.1016/j.ejvs.2018.10.038. Epub 2019 Mar 20.
The aim was to determine the mode of presentation and 30 day procedural risks in 4418 patients with 4743 carotid body tumours (CBTs) undergoing surgical excision.
This is a systematic review and meta-analysis of 104 observational studies.
Overall, 4418 patients with 4743 CBTs were identified. The mean age was 47 years, with the majority being female (65%). The commonest presentation was a neck mass (75%), of which 85% were painless. Dysphagia, cranial nerve injury (CNI), and headache were present in 3%, while virtually no one presented with a transient ischaemic attack (0.26%) or stroke (0.09%). The majority (97%) underwent excision, but only 21% underwent pre-operative embolisation. Overall, 27% were Shamblin I CBTs; 44% were Shamblin II; and 29% were Shamblin III. The mean 30 day mortality was 2.29% (95% CI 1.79-2.93). The mean 30 day stroke rate was 3.53% (95% CI 2.91-4.29), while the mean 30 day CNI rate was 25.4% (95% CI 24.5-31.22). The prevalence of persisting CNI at 30 days was 11.15% (95% CI 8.42-14.64). Twelve series (544 patients) correlated 30 day stroke with Shamblin status. Shamblin I CBTs were associated with a 1.89% stroke rate (95% CI 0.92-3.82), increasing to 2.71% (95% CI 1.43-5.07) for Shamblin II CBTs and 3.99% (95% CI 2.34-6.74) for Shamblin III tumours. Twenty-six series (1075 patients) correlated CNI rates with Shamblin status: 3.76% (95% CI 2.62-5.35) for Shamblin I CBTs, 14.14% (95% CI 11.94-16.68) for Shamblin II, and 17.10% (95% CI 14.82-19.65) for Shamblin III tumours. The prevalence of neck haematoma requiring re-exploration was 5.24% (95% CI 3.45-7.91). The proportion of patients with a neck haematoma requiring re-exploration was not reduced by pre-operative embolisation (5.92%; 95% CI 2.56-13.08) vs. no embolisation (5.82%; 95% CI 2.76-11.88). Pre-operative embolisation did not reduce drainage losses (639 mL vs. 653 mL).
This is the largest meta-analysis of outcomes after CBT excision. Procedural risks associated with tumour excision were considerable, especially with Shamblin III tumours where 4% suffered a peri-operative stroke and 17% suffered a CNI.
旨在确定 4418 例 4743 个颈动脉体瘤(CBT)患者的手术切除方式和 30 天手术风险。
这是对 104 项观察性研究的系统评价和荟萃分析。
共确定了 4418 例 4743 例 CBT 患者。平均年龄为 47 岁,大多数为女性(65%)。最常见的表现为颈部肿块(75%),其中 85%为无痛性。吞咽困难、颅神经损伤(CNI)和头痛的发生率分别为 3%,而实际上没有患者出现短暂性脑缺血发作(0.26%)或中风(0.09%)。大多数(97%)患者接受了切除术,但只有 21%的患者接受了术前栓塞。总体而言,27%为 Shamblin I CBTs;44%为 Shamblin II;29%为 Shamblin III。30 天死亡率的平均值为 2.29%(95%CI 1.79-2.93)。30 天卒中发生率的平均值为 3.53%(95%CI 2.91-4.29),而 30 天 CNI 发生率的平均值为 25.4%(95%CI 24.5-31.22)。30 天持续 CNI 的患病率为 11.15%(95%CI 8.42-14.64)。12 项研究(544 例患者)将 30 天卒中与 Shamblin 状态相关联。Shamblin I CBT 的卒中发生率为 1.89%(95%CI 0.92-3.82),Shamblin II CBT 增加至 2.71%(95%CI 1.43-5.07),Shamblin III 肿瘤增加至 3.99%(95%CI 2.34-6.74)。26 项研究(1075 例患者)将 CNI 发生率与 Shamblin 状态相关联:Shamblin I CBT 为 3.76%(95%CI 2.62-5.35),Shamblin II 为 14.14%(95%CI 11.94-16.68),Shamblin III 为 17.10%(95%CI 14.82-19.65)。需要再次探查的颈部血肿发生率为 5.24%(95%CI 3.45-7.91)。需要再次探查的颈部血肿患者比例不因术前栓塞(5.92%;95%CI 2.56-13.08)而减少,也不因无栓塞(5.82%;95%CI 2.76-11.88)而减少。术前栓塞并未减少引流损失(639ml 比 653ml)。
这是最大的 CBT 切除术后结果荟萃分析。与肿瘤切除相关的手术风险相当大,特别是 Shamblin III 肿瘤,其中 4%的患者在围手术期发生卒中,17%的患者发生 CNI。